Company name | Market Cap | Momentum score | Last Price | 52w high | 52w low | 1d change | 1w change | 1m change | 3m change | 6m change | 1y change | 3y change | 5y change | 10y change | 3y CAGR | 5y CAGR | 10y CAGR | % of 52w high | % of 52w low |
$8,236.6M | 5.3 | $65.2 1.3% | $65.2 | $37.8 | 1.3% | 4.6% | 12.8% | 38.2% | 11.3% | 62.0% | 75.2% | 287.4% | 363.8% | 20.5% | 40.3% | 18.6% | 100.0% | 172.3% | |
$129.6B | 3.0 | $503.2 (1.4%) | $516.7 | $392.8 | (1.4%) | (0.3%) | 3.9% | 24.2% | 9.4% | 21.0% | 101.1% | 148.9% | 300.0% | 26.2% | 25.6% | 16.7% | 97.4% | 128.1% | |
$70.9B | 4.1 | $658.5 (0.6%) | $1,200.2 | $658.5 | (0.6%) | (1.3%) | (6.0%) | (7.8%) | (39.6%) | (31.9%) | (4.9%) | 44.7% | 37.8% | (1.7%) | 9.7% | 3.6% | 54.9% | 100.0% | |
$43.6B | 9.1 | $615.0 0.3% | $671.8 | $356.0 | 0.3% | 1.7% | (4.6%) | (2.1%) | 16.4% | 55.0% | 106.0% | 376.8% | 2,574.0% | 27.2% | 47.8% | 59.9% | 91.6% | 172.8% | |
$36.4B | 4.6 | $283.3 11.7% | $300.6 | $143.3 | 11.7% | 17.2% | 13.1% | 17.0% | 4.2% | 93.2% | 74.4% | 186.0% | 154.1% | 20.4% | 30.0% | 10.9% | 94.3% | 197.7% | |
$22.9B | 5.8 | $95.4 (0.9%) | $126.9 | $78.4 | (0.9%) | (4.1%) | (20.5%) | (16.0%) | (15.6%) | 3.7% | (43.2%) | 88.4% | 578.7% | (17.2%) | 17.2% | 46.7% | 75.2% | 121.7% | |
$15.1B | 2.3 | $33.7 0.6% | $33.9 | $24.1 | 0.6% | 2.8% | 0.8% | 34.4% | 23.4% | 14.1% | (6.6%) | (15.9%) | (15.9%) | (2.3%) | (4.2%) | (4.2%) | 99.5% | 139.7% | |
$14.3B | 8.0 | $19.8 1.6% | $31.9 | $2.4 | 1.6% | (5.0%) | (10.7%) | 5.8% | (9.9%) | 456.3% | 507.7% | 858.7% | 62.0% | 82.5% | 76.0% | 5.5% | 61.9% | 826.4% | |
$14.0B | 7.5 | $313.0 (0.2%) | $410.0 | $228.3 | (0.2%) | 1.9% | (13.3%) | (13.9%) | (12.0%) | 32.1% | 71.8% | 272.8% | 75.1% | 19.8% | 39.0% | 6.4% | 76.3% | 137.1% | |
$13.6B | 3.4 | $71.2 (0.5%) | $93.8 | $61.3 | (0.5%) | 2.6% | 4.4% | 7.5% | 3.1% | (15.3%) | (12.2%) | (0.2%) | (42.4%) | (4.3%) | (0.0%) | (5.9%) | 75.9% | 116.3% | |
$1,846.9M | 9.0 | $226.7 0.0% | $246.0 | $129.5 | 0.0% | 2.0% | 23.3% | 4.7% | 40.9% | 39.9% | (6.5%) | 45.2% | 700.5% | (3.3%) | 7.7% | 29.7% | 92.1% | 175.0% |
Halozyme Therapeutics, Inc. (HALO) 1-month return is 12.8%, compared to the (5.7%) return of the S&P 500.
Halozyme Therapeutics, Inc. (HALO) YTD return is 74.3%, compared to the 19.5% return of the S&P 500.
Halozyme Therapeutics, Inc. (HALO) 1-year return is 62.0%, compared to the 8.1% return of the S&P 500.
Halozyme Therapeutics, Inc. (HALO) 3-year return is 75.2%, compared to the 27.0% return of the S&P 500.